Favipiravir versus standard of care in patients with severe COVID-19 infections: A retrospective comparative study.

Objective: To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection.

Methods: This is a retrospective cohort of patients with COVID-19 pneumonia who were treated with favipiravir, versus comparison group that received the standard of care.

Results: A total of 226 patients were included; 110 patients received favipiravir and 116 patients received standard of care.